New Canadian study to assess medical cannabis for arthritis treatment

Warning message

The subscription service is currently unavailable. Please try again later.

Researchers in Canada are to carry out a new study that will assess the potential benefits that medical cannabis can provide for arthritis patients.

Canada’s Arthritis Society is providing a three-year research grant to Dr Jason McDougall of Dalhousie University, a leading pain researcher, to investigate the drug’s impact on arthritis pain and disease management.

Specifically, it will examine the ability of cannabis-like compounds to repair joint nerves and thereby relieve neuropathic pain from osteoarthritis. Dr McDougall’s project was selected following an extensive multi-disciplinary peer review process ranking competing submissions from a number of Canadian researchers.

This will provide fresh insights not only into the medical applications of cannabis, but also into the emerging theory that much of the pain felt by osteoarthritis sufferers is neuropathic in nature, meaning it is caused by nervous system damage rather than joint degeneration.

Should this be proven true, it would help explain why current therapies...

Rate this article: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.